Comparing two injection techniques for treating frozen shoulder
Therapeutic Effect of Shoulder Anterior Capsular Block (SHAC) Versus Suprascapular Nerve Block in Patients With Frozen Shoulder
This study is testing which of two injection methods works better to relieve pain and improve movement for people with frozen shoulder.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 19 Years to 65 Years |
| Sex | All |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06725823 on ClinicalTrials.gov |
What this trial studies
This study involves 50 patients suffering from frozen shoulder, who will be randomly assigned to receive either a suprascapular nerve block or a shoulder anterior capsular block. The shoulder anterior capsular block involves an ultrasound-guided injection targeting the glenohumeral pericapsular space, while the suprascapular nerve block targets the suprascapular nerve using a high-frequency ultrasound probe. The aim is to evaluate the effectiveness of these two techniques in alleviating symptoms and improving shoulder mobility. The study will not include healthy volunteers, focusing solely on patients with a history of shoulder complaints lasting over six weeks.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years with unilateral frozen shoulder symptoms lasting more than six weeks.
Not a fit: Patients with allergies to local anesthetics, infections at the injection site, or those who have had recent shoulder injections may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide patients with more effective pain relief and improved mobility for frozen shoulder.
How similar studies have performed: While there have been studies on nerve blocks for shoulder pain, the specific comparison of these two techniques in frozen shoulder is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age above 18 years. * Both sexes, males and females. * History of complaint \>6 weeks * Restricted shoulder movement unilaterally in at least 2 planes including abduction, external rotation, and internal rotation and restricted passive movement. Exclusion Criteria: * Patient refusal. * -Allergy to local anaesthetics. * -Infection at the site of injection . * -Coagulopathy * -Prolonged opioid medication * -Pregnancy * -Acute trauma, fracture of the shoulder * People who had received an intra-articular shoulder injection within the last 6 months. * Patients with tendon tear
Where this trial is running
Sohag
- Sohag university — Sohag, Egypt (Recruiting)
Study contacts
- Study coordinator: Hanan Sayed Mohamed AboZaid, Professor
- Email: hanan72eg@yahoo.com
- Phone: 01017049050
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.